Deng M, Zhang B, Wang K, Liu F, Xiao H, Zhao J, et al
Lillys Zepbound, approved in November 2023 as the Indiana-based drug giants answer to Novo Nordisks Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase 3 trial, and a mid-stage study of another Lilly experimental medicine, called retatrutide, showed 24% weight loss after just 48 weeks
Nor can a doctor know the ideal dose of a compound when reliable dose-finding studies do not exist
It remains important that correlative and mechanistic studies continue to unpick the complex immune response to coronaviruses to hone-in on which aspects of immunity are most effective against coronaviruses to inform vaccine design
By doing so, semaglutide has proven to be a highly effective tool for improving blood sugar control, promoting weight loss, and reducing the risk of complications associated with diabetes and obesity
With this change in thyroid hormone metabolism, its no wonder that thyroidectomy patients struggle with weight gain